Nuveen Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-134,791
| Closed | -$42.7M | – | 3318 |
|
2023
Q4 | $42.7M | Sell |
134,791
-25,782
| -16% | -$8.16M | 0.01% | 680 |
|
2023
Q3 | $27.2M | Buy |
160,573
+10,275
| +7% | +$1.74M | 0.01% | 860 |
|
2023
Q2 | $32.6M | Buy |
150,298
+3,071
| +2% | +$666K | 0.01% | 769 |
|
2023
Q1 | $26.7M | Buy |
147,227
+37,370
| +34% | +$6.79M | 0.01% | 857 |
|
2022
Q4 | $21.6M | Buy |
109,857
+12,871
| +13% | +$2.53M | 0.01% | 985 |
|
2022
Q3 | $21.8M | Buy |
96,986
+21,681
| +29% | +$4.88M | 0.01% | 952 |
|
2022
Q2 | $1.33M | Buy |
75,305
+9,848
| +15% | +$174K | ﹤0.01% | 2659 |
|
2022
Q1 | $1.16M | Sell |
65,457
-536
| -0.8% | -$9.47K | ﹤0.01% | 2760 |
|
2021
Q4 | $1.17M | Sell |
65,993
-6,030
| -8% | -$107K | ﹤0.01% | 2805 |
|
2021
Q3 | $1.27M | Sell |
72,023
-13,155
| -15% | -$233K | ﹤0.01% | 2887 |
|
2021
Q2 | $1.51M | Buy |
85,178
+16,881
| +25% | +$298K | ﹤0.01% | 2831 |
|
2021
Q1 | $1.21M | Sell |
68,297
-469
| -0.7% | -$8.29K | ﹤0.01% | 2831 |
|
2020
Q4 | $1.22M | Sell |
68,766
-1,774
| -3% | -$31.4K | ﹤0.01% | 2736 |
|
2020
Q3 | $1.25M | Sell |
70,540
-1,883
| -3% | -$33.3K | ﹤0.01% | 2596 |
|
2020
Q2 | $1.28M | Buy |
72,423
+27,392
| +61% | +$485K | ﹤0.01% | 2516 |
|
2020
Q1 | $3.24M | Buy |
45,031
+22,538
| +100% | +$1.62M | ﹤0.01% | 1945 |
|
2019
Q4 | $1.7M | Buy |
+22,493
| New | +$1.7M | ﹤0.01% | 2492 |
|